ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.331,39
-0,25%
S&P 500
5.469,30
0,39%
US Dollar vs BRL
5,4508
-0,03%
Bitcoin
61.412,44
-0,64%
Brent Oil
84,805
0,74%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. Navamedic Asa (0FDB)

  7. Navamedic Asa (0FDB) Notícias

0FDB

Navamedic Asa (0FDB)

Navamedic Asa
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:0FDB
DataHoraFonteTítuloCódigoCompanhia
21/12/202313:29PR Newswire (US)Navamedic ASA: Renewed contract signed with Vitaflo International LimitedLSE:0FDBNavamedic Asa
13/12/202315:18PR Newswire (US)Navamedic and Orion Corporation sign non-binding term sheet for Flexilev®in EuropeLSE:0FDBNavamedic Asa
01/11/202304:14PR Newswire (US)Navamedic ASA: Record high quarter with above 50 percent growthLSE:0FDBNavamedic Asa
27/10/202306:52PR Newswire (US)Navamedic ASA: Invitation to 2023 3rd quarter presentationLSE:0FDBNavamedic Asa
30/08/202308:20PR Newswire (US)Navamedic ASA - Registration of share capital increaseLSE:0FDBNavamedic Asa
18/08/202307:50PR Newswire (US)Navamedic ASA - Mandatory notification of trade by primary insiderLSE:0FDBNavamedic Asa
18/08/202307:27PR Newswire (US)NAVAMEDIC ASA: Resolution to increase the share capital in connection with exercise of employee optionsLSE:0FDBNavamedic Asa
11/08/202303:41PR Newswire (US)Navamedic ASA: Significant growth across the businessLSE:0FDBNavamedic Asa
07/08/202307:40PR Newswire (US)Navamedic ASA: Invitation to 2023 2nd quarter presentationLSE:0FDBNavamedic Asa
01/06/202306:43PR Newswire (US)Navamedic ASA: Minutes of Annual General MeetingLSE:0FDBNavamedic Asa
31/05/202309:42PR Newswire (US)Updated recommendation by the nomination committee of Navamedic ASALSE:0FDBNavamedic Asa
26/05/202303:23PR Newswire (US)Navamedic to own a total of 96.33 per cent of shares in Sensidose following closing of public offerLSE:0FDBNavamedic Asa
11/05/202307:15PR Newswire (US)Navamedic ASA: Notice of Annual General MeetingLSE:0FDBNavamedic Asa
11/05/202303:57PR Newswire (US)Navamedic ASA Q1 2023: Another strong quarterLSE:0FDBNavamedic Asa
10/05/202304:15PR Newswire (US)Navamedic increases the consideration to SEK 8.50 in cash per share in its unconditional public offer and convenes an extraordinary general meeting of Sensidose AktiebolagLSE:0FDBNavamedic Asa
08/05/202306:25PR Newswire (US)Navamedic ASA: Invitation to 2023 1st quarter presentationLSE:0FDBNavamedic Asa
28/04/202308:57PR Newswire (US)Navamedic ASA: Annual Report for 2022LSE:0FDBNavamedic Asa
24/04/202300:34PR Newswire (US)Navamedic ASA: Amended cash offer to acquire Sensidose AB and acquisition of shares in Sensidose ABLSE:0FDBNavamedic Asa
29/03/202303:13PR Newswire (US)Navamedic ASA: Recommended cash offer to acquire Sensidose for approximately SEK 75 millionLSE:0FDBNavamedic Asa
16/02/202305:00PR Newswire (US)Navamedic ASA: Q4 2022 financial resultsLSE:0FDBNavamedic Asa
13/02/202305:19PR Newswire (US)Navamedic ASA: Invitation to 2022 4th quarter presentationLSE:0FDBNavamedic Asa
23/11/202207:30PR Newswire (US)Navamedic ASA acquires innovative antibiotic product for hospital use in the Nordic regionLSE:0FDBNavamedic Asa
01/11/202204:43PR Newswire (US)Navamedic ASA: Q3 2022 financial resultsLSE:0FDBNavamedic Asa
25/10/202211:01PR Newswire (US)Navamedic ASA: Invitation to 2022 third quarter presentationLSE:0FDBNavamedic Asa
20/10/202204:24PR Newswire (US)Navamedic ASA launches ForlaxGO® - an innovative on-the-go product for the treatment of constipationLSE:0FDBNavamedic Asa
12/08/202203:48PR Newswire (US)Navamedic ASA: Q2 and first half 2022 financial resultsLSE:0FDBNavamedic Asa
09/08/202209:40PR Newswire (US)Navamedic ASA: Invitation to 2022 second quarter presentationLSE:0FDBNavamedic Asa
04/08/202209:27PR Newswire (US)Navamedic ASA - Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig®LSE:0FDBNavamedic Asa
04/07/202215:13PR Newswire (US)Navamedic ASA: Trading UpdateLSE:0FDBNavamedic Asa
01/06/202211:50PR Newswire (US)Navamedic ASA completes acquisition of Impolin AB and issues consideration sharesLSE:0FDBNavamedic Asa
 Apresentando as notícias mais relevantes sobre:LSE:0FDB

Seu Histórico Recente

FX
CVEEUR
CVE vs Euro
LSE
SUSU
Is $cp 0-3 Esg
EU
4912T
4912T
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados